ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis (HERALD): a randomised, double-blind, placebo-controlled, phase 2a trial

Study limitation reported by the research below: “ALG-055009 has no approved brand name or RxNorm canonical generic entry as of the knowledge cutoff; it is an investigational compound only.”